Literature DB >> 8059605

Senile plaques do not progressively accumulate with normal aging.

I R Mackenzie1.   

Abstract

Senile plaques (SP) are one of the pathologic hallmarks of Alzheimer's disease (AD). Models of SP formation, particularly the early stages, could provide valuable insight into AD pathogenesis. One such model may be provided by non-demented elderly individuals in whom some SP are a common incidental finding. This study has examined post-mortem brain tissue from a large number of such neurologically normal patients in an attempt to better understand the temporal sequence of SP formation. SP were identified in modified Bielschowsky-stained sections of mesial temporal lobe in 122 (30%) of 402 cases. The prevalence of SP in the temporal neocortex correlated strongly with patient age. Surprisingly, however, neither the mean nor maximum SP density showed any increase with age. This suggests that SP do not progressively accumulate in normal aging but develop over a limited time period after which their number stabilizes at a constant level. In most cases, all SP were of the diffuse type. In 37 cases (9%), however, some neuritic SP (NP) were also seen. Although the NP density did not show a significant increase with age either, the proportion of SP which were neuritic (NP/SP), did. This suggests that changes in SP morphology may be more important than total SP numbers in normal aging.

Entities:  

Mesh:

Year:  1994        PMID: 8059605     DOI: 10.1007/bf00294179

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  44 in total

1.  Amyloid precursor protein gene mutation in early-onset Alzheimer's disease.

Authors:  C M van Duijn; L Hendriks; M Cruts; J A Hardy; A Hofman; C Van Broeckhoven
Journal:  Lancet       Date:  1991-04-20       Impact factor: 79.321

2.  Diffuse type of senile plaques in the brains of Alzheimer-type dementia.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Harigaya
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

Authors:  N Kitaguchi; Y Takahashi; Y Tokushima; S Shiojiri; H Ito
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

4.  Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes.

Authors:  C Bouras; P R Hof; J H Morrison
Journal:  Neurosci Lett       Date:  1993-04-30       Impact factor: 3.046

5.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

6.  Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain.

Authors:  H Yamaguchi; C Haga; S Hirai; Y Nakazato; K Kosaka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  The topographic distribution of senile plaques and neurofibrillary tangles in the brains of non-demented persons of different ages.

Authors:  D M Mann; C M Tucker; P O Yates
Journal:  Neuropathol Appl Neurobiol       Date:  1987 Mar-Apr       Impact factor: 8.090

8.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

9.  The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy.

Authors:  D M Mann; B Marcyniuk; P O Yates; D Neary; J S Snowden
Journal:  Neuropathol Appl Neurobiol       Date:  1988 May-Jun       Impact factor: 8.090

10.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

Authors:  R E Tanzi; J F Gusella; P C Watkins; G A Bruns; P St George-Hyslop; M L Van Keuren; D Patterson; S Pagan; D M Kurnit; R L Neve
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

View more
  7 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

2.  Senile plaques, "aging" and Alzheimer's disease.

Authors:  J F Foncin; K H el Hachimi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 3.  Causes of Alzheimer's disease.

Authors:  D G Munoz; H Feldman
Journal:  CMAJ       Date:  2000-01-11       Impact factor: 8.262

4.  Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients.

Authors:  M Huell; S Strauss; B Volk; M Berger; J Bauer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  Cerebral beta amyloid deposition in patients with malignant neoplasms: its prevalence with aging and effects of radiation therapy on vascular amyloid.

Authors:  S Sugihara; A Ogawa; Y Nakazato; H Yamaguchi
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Evidence of Tau Hyperphosphorylation and Dystrophic Microglia in the Common Marmoset.

Authors:  Juan D Rodriguez-Callejas; Eberhard Fuchs; Claudia Perez-Cruz
Journal:  Front Aging Neurosci       Date:  2016-12-22       Impact factor: 5.750

7.  Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer's disease.

Authors:  Umamon Puangthong; Ging-Yuek Robin Hsiung
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.